Carregant...
Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer
BACKGROUND: The tumorigenesis of prostate cancer involves genetic mutations. Tumour mutational burden (TMB) is an emerging biomarker for predicting the efficacy of immunotherapy. RESULTS: Single-nucleotide polymorphisms were the most common variant type, and C>T transversion was the most commonly...
Guardat en:
| Publicat a: | BMC Urol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7905899/ https://ncbi.nlm.nih.gov/pubmed/33632199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-021-00795-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|